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Epidermal Development and Wound Healing
in Matrix Metalloproteinase 13-Deficient Mice
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Sibylle Teurich1, Marina Schorpp-Kistner1, Zena Werb2 and Peter Angel1
Degradation of the extracellular matrix, which is an indispensable step in tissue remodelling processes such as
embryonic development and wound healing of the skin, has been attributed to collagenolytic activity of
members of the matrix metalloproteinase family (MMPs). Here, we employed mmp13 knockout mice to
elucidate the function of MMP13 in embryonic skin development, skin homeostasis, and cutaneous wound
healing. Overall epidermal architecture and dermal composition of non-injured skin were indistinguishable
from wild-type mice. Despite robust expression of MMP13 in the early phase of wound healing, wild-type and
mmp13 knockout animals did not differ in their efficiency of re-epithelialization, inflammatory response,
granulation tissue formation, angiogenesis, and restoration of basement membrane. Yet, among other MMPs
also expressed during wound healing, MMP8 was found to be enhanced in wounds of MMP13-deficient mice.
In summary, skin homeostasis and also tissue remodelling processes like embryonic skin development and
cutaneous wound healing are independent of MMP13 either owing to MMP13 dispensability or owing to
functional substitution by other collagenolytic proteinases such as MMP8.
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INTRODUCTION
Matrix metalloproteinases (MMPs), a family of structurally
related neutral endopeptidases, play a central role in the
breakdown of extracellular matrix (ECM). ECM degradation is
essential for normal connective tissue remodelling in
embryonic growth and development, morphogenesis, bone
growth and resorption, wound healing, and uterine involu-
tion (Matrisian, 1992; Birkedal-Hansen et al., 1993; Nagase
and Woessner, 1999; Vu and Werb, 2000; Stamenkovic,
2003). Additionally, incorrect regulation of MMPs is pro-
posed to contribute to a variety of pathological processes
characterized by increased matrix breakdown such as
rheumatoid arthritis, atherosclerosis, and tumor invasion
and metastasis (Mauch et al., 1993; Basset et al., 1997;
Balbin et al., 2001, 2003; Neuhold et al., 2001). All MMPs
display a conserved catalytic Zn2þ binding site and can be
inhibited by specific physiologic inhibitors, the tissue
inhibitor of metalloproteinase (for review, see Vu and Werb,
2000; Sternlicht and Werb, 2001; Stamenkovic, 2003). At
present, 25 different human MMPs have been characterized
at the amino-acid sequence level (for review, see Vu and
Werb, 2000; McCawley and Matrisian, 2001; Lynch and
Matrisian, 2002). Closely related members of the MMPs are
often classified into different subfamilies of collagenases,
gelatinases, stromelysins, matrilysins, membrane-type MMPs,
and other MMPs (for review, see Nagase and Woessner,
1999; Vu and Werb, 2000; Sternlicht and Werb, 2001). The
collagenase subfamily of human MMPs comprises three
different members: the fibroblast interstitial collagenase
(MMP1), the neutrophil collagenase (MMP8), and collage-
nase-3 (MMP13). To date, homologues in mice have been
identified for MMP8 and MMP13 but not for MMP1. In mouse
and rat, MMP1 appears to be functionally substituted by other
collagenolytic enzymes such as MMP13, MMP14 (MT1-
MMP), and McolA (Mariani et al., 1998; Balbin et al., 2001;
Wu et al., 2003). Collagenases are the only members of the
MMP family that degrade native fibrillar collagens in the
triple helical domain in vivo (Krane et al., 1996; for review,
see Massova et al., 1998; Vu and Werb, 2000; Balbin et al.,
2001; Sternlicht and Werb, 2001; Egeblad and Werb, 2002;
Stamenkovic, 2003). Therefore, collagenases are thought to
execute a rate-limiting function in ECM re-organization that is
essential not only for morphogenesis, but also for tissue
remodelling processes in the adult organism, such as
cutaneous wound healing.
This repair process, which provides an entirely restored
barrier to protect the body from external environmental
exposition, involves multiple distinct processes including
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(1) migration, proliferation, and re-stratification of keratino-
cytes into a multilayered structure, (2) infiltration of
inflammatory cells and formation of the granulation tissue,
(3) neovascularization, and (4) restoration of stable adhesive
interaction with the underlying dermal stroma (for review, see
Fuchs, 1990; Singer and Clark, 1999). During wound healing,
the ECM undergoes a dramatic re-organization at the wound
site, mainly accomplished by the action of MMPs (Clark,
1996; Ravanti and Kahari, 2000; Vu and Werb, 2000). In
addition, MMP activity causes the release of cryptic
information from the ECM. By cleaving large ECM compo-
nents and ECM-associated molecules, MMPs liberate bioac-
tive fragments and molecules (Schenk and Quaranta, 2003;
Mott and Werb, 2004) and thereby regulate angiogenesis (Xu
et al., 2001; Hangai et al., 2002) and release growth factors
and cytokines (Yu and Stamenkovic, 2000; Dangelo et al.,
2001; Mu et al., 2002; Belotti et al., 2003). Thus, ECM
proteolysis executed by MMPs may be a prerequisite for
proper wound repair and accurate tissue regeneration.
Degradation of the ECM that enables the movement of
migrating keratinocytes between the collagenous dermis and
the fibrin matrix deposited within hours after injury (Singer
and Clark, 1999) presumably depends on the production of
collagenolytic proteases produced by the keratinocytes
(Pilcher et al., 1997; for review, see Seiki, 2002; Beare
et al., 2003; Stamenkovic, 2003). Moreover, secretion of
different MMPs by inflammatory cells such as neutrophils and
macrophages facilitates infiltration into the granulation tissue
(Clark, 1996; Beare et al., 2003). MMPs produced by the
endothelial cells of newly formed blood vessels (Hiraoka
et al., 1998; Werb et al., 1999; Langlois et al., 2004; Warner
et al., 2004) may participate in angiogenesis (Singer and
Clark, 1999; Seandel et al., 2001). Although the list of MMPs
found to be expressed in the wound is constantly growing
(Okada et al., 1997; Madlener et al., 1998; Saarialho-Kere,
1998; Lund et al., 1999; Planus et al., 1999; Hieta et al.,
2003), the exact spectrum of MMPs critically involved in
cutaneous wound healing has not been completely unra-
velled so far. Clearly, collagen degradation is required for
keratinocyte migration in culture (Pilcher et al., 1997) and in
vivo (Beare et al., 2003). The strong expression of MMP13 by
migrating keratinocytes at the leading wound edge in the
early phase of the healing process (Madlener et al., 1998) and
its secretion by the dermal fibroblasts in the granulation tissue
(Wu et al., 2003) suggests that this enzyme plays an important
role in wound healing.
In this study, MMP13-deficient mice were generated to
analyze the physiological function of MMP13 during skin
development, homeostasis, and healing of excisional skin
wounds.
RESULTS
Generation and phenotype of MMP13-deficient mice
To determine the role of MMP13 in embryonic skin
development, skin homeostasis, and cutaneous wound
healing, we crossed mice with a floxed mmp13 (mmp13
4/4) locus (Stickens et al., 2004) to CMV-cre deleter
(Schwenk et al., 1995) to obtain ubiquitous disruption of
the mmp13 gene. By inter-crossing offspring, which were
heterozygous for the mutated mmp13 and the cre transgene,
we obtained mmp13 null (mmp13 /), heterozygous
(mmp13 þ /), and wild-type (mmp13 þ /þ ) mice, trans-
genic and non-transgenic for cre, in the expected Mendelian
ratio. Floxed mmp13 mice did not differ from wild-type mice
in MMP13 expression (Stickens et al., 2004, and data not
shown) and were used as controls in this study. Complete cre
recombination and loss of MMP13 transcripts in all tissues of
mmp13 null mice including skin were verified by Southern
blotting (data not shown) and by in situ hybridization
(Figure 2), Northern blot (Figure 5), and reverse transcrip-
tion-PCR (data not shown).
Despite MMP13 deficiency, mice developed normally,
were fertile and showed no gross phenotypic abnormalities,
and long-term survival rates were indistinguishable from their
wild-type littermates and the floxed controls, being in
agreement with published data (Stickens et al., 2004).
Histological examination of back skin of embryonic day
16.5 embryos (Figures 1a and b) and of tail (Figure 1c and d)
and back skin (data not shown) of 7- to 8-week-old mice
revealed by hematoxylin and eosin (H&E) staining showed no
obvious difference between mmp13 4/4 and mmp13 /
in overall morphology. As the epidermis of back skin
comprises only 2–3 keratinocyte layers, we used tail skin
sections to analyze keratinocyte proliferation and epidermal
differentiation pattern in the mutant animals (Figure 1c–j, and
data not shown). No significant difference was observed in
terms of keratinocyte proliferation rate, as demonstrated by
Ki67 staining of tail skin sections (data not shown). Likewise,
expression analysis of (i) keratin-5 (Figure 1e and f), a
cytokeratin protein expressed in the basal keratinocyte layer
of the skin, (ii) involucrin (Figure 1g and h), detectable in all
suprabasal layers, and (iii) loricrin (Figure 1i and j), a protein
representative of the stratum granulosum, indicated normal
keratinocyte differentiation in mmp13 knockout mice.
Epidermal organization and dermal composition in skin of
6- and 12-month-old knockout mice were also unchanged
when compared to controls (data not shown). In addition, we
did not detect obvious increases in collagen deposition,
fibrosis, or any other obvious abnormalities in the dermis of
tail skin (data not shown) and back skin (Figure 1k and l).
These data indicate that loss of MMP13 expression compro-
mises neither proliferation and differentiation of epidermal
keratinocytes nor the function of dermal fibroblasts and other
cell types in mouse skin during embryonic development and
homeostasis in adult mice.
Cutaneous wound healing in mmp13 / mice
To study the physiological role of MMP13 during the healing
process, we generated full-thickness excisional wounds in the
back skin of 8- to 12-week-old mmp13 / and mmp134/4
mice. In agreement with published data (Madlener et al.,
1998), during the early phase of wound healing, we observed
an upregulation of MMP13 in the keratinocytes of the leading
wound edge of wild-type and floxed controls, by in situ
hybridization (Figure 2a, and data not shown). In contrast, in
wounds of mmp13 / mice, MMP13 expression was
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Figure 1. Histopathological analyses of epidermal tissue morphology.
(a, b) H&E of sections from back skin of embryonic day (E)16.5 embryos of
(a) controls and (b) mmp13 / mice. Bar: 100mm. (c–l) Tail skin sections
(c–j) and back skin sections (k, l) of adult mice (left panel: mmp13 4/4 and
right panel: mmp13 /) were either stained with H&E (c, d) or analyzed by
immunofluorescence for (e, f, green signal) keratin-5 and (g, h, red signal)
involucrin expression. Nuclei were counterstained with Hoechst dye (blue
signal). The basement membrane is indicated by a dashed line. (i, j, brown
signal) Loricrin was visualized immunohistochemically and, for this analysis,
nuclei were counterstained with hematoxylin (blue signal). (k, l) Collagen
fibers in the dermis of back skin were stained with Picrosirius red and
visualized by crossed polarization. Bars: 50mm.
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Figure 2. MMP13 expression analysis and microscopic assessment of
wounds in MMP13-deficient mice. (a, b) In situ hybridization for MMP13 on
wounds of (a) mmp13 4/4 controls and (b) mmp13 / mice followed by
H&E staining to detect transcripts on sections of the left-hand site of wounds 1
day post injury. The arrow points to keratinocytes of the leading wound edge.
Bar: 50mm. (c–f) H&E-stained sections of the left-hand site of wounds (c, d)
1 day and (e, f) 3 days after injury. The dashed line indicates basement
membrane. The migrating tip is marked by the dotted line. Bar: 100mm. (g, h)
Full re-epithelialization of mmp13 / and control wounds, as demonstrated
by wound sections taken 3 days post injury and immunostained for involucrin
(red signal). Nuclei were counterstained with Hoechst dye (blue signal),
which also stained the scab. The basement membrane is indicated by a
dashed line. Bar: 100mm. (i–l) Sections of wounds taken 7 days post excision
were immunostained for the differentiation marker (i, j, green signal)
keratin-10 and (k, l, red signal) loricrin to demonstrate complete keratinocyte
differentiation. Nuclei were counterstained with Hoechst dye (blue signal).
The dashed line indicates basement membrane. Bars: 100mm.
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extinguished (Figure 2b), confirming MMP13 deficiency in
skin keratinocytes.
Macroscopic examination of wounds from mmp13 /
and control animals revealed a comparable healing process in
all individuals tested (data not shown). To assess the re-
epithelialization potential of mmp13 / keratinocytes from
day 1 to 10 post wounding, we applied detailed histological
analysis of knockout and control wounds and studied
keratinocyte differentiation pattern and wound closure kinetics
(Figures 2c–l and Figure S1, and data not shown). In all cases,
24 hours post injury wound beds of both strains were just
covered by a fibrin clot, and keratinocytes had not yet formed
a continuous layer (Figure 2c and d). In some instances,
wounds of mmp13 / as well as mmp13 4/4 mice were
already re-epithelialized at day 3 after wounding. This was
evidenced by a complete keratinocyte layer (Figure 2e and f)
and continuous involucrin staining throughout the former
wound area (Figure 2g and h). In both strains, epidermal re-
organization was completed 7 days post wounding, as proven
by staining with antibodies against the early differentiation
marker keratin-10 (Figure 2i and j) and the late differentiation
marker loricrin (Figure 2k and l). Both proteins were expressed
at normal levels and within the adequate layers. Measuring the
distance between the leading wound edges on sections of
mmp13 / and control mice at different time points after
wounding revealed no significant difference in wound closure
at days 2, 3, and 5 (Figure S1).
These data show that re-epithelialization after cutaneous
injury is not significantly affected even though MMP13
expression is lost in the keratinocytes of the leading wound
edge, suggesting either that MMP13 is not required during
this process or can be functionally replaced by other MMPs.
Granulation tissue formation and angiogenesis at the wound sites
Dermal fibroblasts of the granulation tissue express reason-
able amounts of MMP13 (Madlener et al., 1998; Wu et al.,
2003), suggesting a contribution of this protease in granula-
tion tissue formation and angiogenesis. Therefore, we
explored the size and composition of the granulation tissue
in wounds of mmp13 / and control animals. Concerning
the size of the granulation tissue, which was visible in both
strains 2–3 days post wounding (Figure 3c–h), no alterations
were found in wounds of mmp13 null mice compared to the
floxed controls (Figure 3, and data not shown). To determine
the inflammatory response, tissue sections were analyzed for
the infiltration of macrophages and neutrophils. As shown in
Figure 3a–d, the number of infiltrated neutrophils was
comparable in wounds of mmp13 / and mmp13 4/4
mice. Similar data were observed for the number of infiltrated
macrophages (Figure 3g and h).
Angiogenesis, one of the important events during wound
healing, was explored on wound sections of MMP13-
deficient and mmp13 floxed mice by CD31 immunostaining.
No significant differences in vessel density and size were
observed in uninjured skin (data not shown) or 7 days after
injury (Figure 3i–l). These data imply that MMP13 deficiency
interferes neither with the formation of granulation tissue nor
with angiogenesis at cutaneous wound sites.
Basement membrane and dermal re-organization at the wound
sites in MMP13-deficient mice
To re-establish proper dermal–epidermal junctions after re-
epithelialization, an intact basement membrane has to be
reconstituted by keratinocytes and fibroblasts. Recently,
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Figure 3. Histological analyses of the granulation tissue at wound sites of
mmp13 / mice. (a–d) Neutrophils located in the granulation tissue of (a, b)
day 1 and (c, d) day 2 wounds of mmp13 4/4 (left panel) and mmp13 /
(right panel) mice were stained by immunofluorescence (red signal) using the
antibody neutrophils. Nuclei were counterstained with Hoechst dye (blue
signal). The basement membrane is depicted by a dashed line and the
granulation tissue is highlighted by a dotted line. (e–h) Bar: 100mm. (e, f) H&E
staining and staining of macrophages by (g, h, red signal) CD68 immuno-
fluorescence on wound sections 3 days post wounding. Bar: 300mm.
(i–l) H&E staining (i, j) and staining of endothelial cells by (k, l, red signal)
CD31 immunofluorescence on wound sections 7 days after wounding.
Bars: 300mm.
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components of the basement membrane, such as perlecan
and laminin-5, and cell surface receptors, such as integrins
and dystroglycans, which interact with the basement
membrane network, have been demonstrated to be substrates
of a number of MMPs including MMP13 (Mott and Werb,
2004).
To demonstrate a possible function of MMP13 in the
regeneration of basal lamina, we followed the deposition
of various basement membrane components during the
wound healing process. Immunostaining of histological
sections for laminin-5 (Figure 4a–d), a6-integrin (Figure
4e–h), perlecan, and nidogen (data not shown) revealed no
differences in protein expression pattern and intensity
between wounds of mmp13 knockout and control mice.
These data indicate that basement membrane re-organization
after wound repair appears to be unaffected by the loss of
MMP13 activity.
Large amounts of ECM proteins, most prominently
collagens, are synthesized, deposited, and remodelled during
wound healing until the final reconstitution of the dermal
matrix is achieved. To follow the expression level and quality
of the collagen network, fibrillar collagen was visualized by
Picrosirius staining throughout the course of wound healing
on sections of control and mmp13 knockout mice from day 1
to 30 post wounding (Figure 4i–n, and data not shown). We
could not detect any obvious abnormalities in the distribu-
tion, mass, or arrangement of the collagen fibers in the
dermal compartment of the MMP13-deficient wounds. These
data demonstrate that loss of MMP13 enzyme activity does
not affect the formation and remodelling of fibrillar collagen
during the entire wound healing process and indicate that a
high degree of functional redundancy between MMP13 and
other members of the MMP family occurs during initial and
late phase of remodelling and tissue repair.
Expression pattern of MMPs in wounds of MMP13-deficient
mice
In wild-type and mmp13 floxed mice, highest MMP13
expression levels were observed 1 and 2 days post wounding
(Figure 5c, and data not shown; Madlener et al., 1998). To
narrow down the potential candidates compensating for
MMP13 deficiency in mutant mice during this early phase of
wound healing, we determined the expression of other MMPs
found in wounds shortly after injury (Figure 5).
The first candidate we analyzed was MMP9, which is
frequently expressed at sites of active tissue remodelling such
as the moving epidermal layer in cutaneous wounds (Salo
et al., 1994; Mohan et al., 1998; Lund et al., 1999) and
functionally cooperates with MMP13 in long bone develop-
ment and homeostasis (Inada et al., 2004; Stickens
et al., 2004). In agreement with published data (Lund et al.,
1999), MMP9 expression originated predominantly from
keratinocytes, which are located at the leading edge of
the wound (Figure 5a and b), and completely overlapped
with the pattern of MMP13-expressing cells in wild-type
mice (Figure 2a). Upon quantification however, the amount
of MMP9 transcripts was not significantly enhanced
compared to wounds of floxed controls, as shown by
−/−
a b
c d
e f
g h
i j
k l
m n
Day 2 L-5
Day 2 6
6
Day 14
Day 14
Day 14 Collagen
Day 14 Collagen
Day 30 Collagen
L-5
>/>
Figure 4. Immunofluorescence analyses of basement membrane re-organi-
zation and visualization of dermal collagen fibers in wounds of mmp13 /
mice. (a–h) Laminin-5 (a–d, green signal) and (e–h, red signal) a6-integrin
were visualized by immunofluorescence on sections of mmp13 4/4 (left
panel) and mmp13 / (right panel) wounds analyzed 2 and 14 days after
injury. Nuclei were counterstained with Hoechst dye (blue signal). Bars:
100mm. (i–n) To visualize collagen fibers of wounds taken at (i–l, bar: 50mm)
day 14 and (m, n, bar: 30mm) day 30, sections were stained by Picrosirius red
and documented by both (i, j) bright field and (k–n) crossed polarization.
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Northern blot analysis of RNA prepared from day 1 and 2
wounds (Figure 5c).
Two other MMPs that are capable of cleaving native,
undenatured fibrillar collagens in vivo are MMP8, which is
predominantly expressed by neutrophils invading the wound
area (Devarajan et al., 1991; Krane et al., 1996; Balbin et al.,
1998), and McolA, the putative murine counterpart of the
human interstitial collagenase MMP1 (Balbin et al., 2001).
Although McolA expression has only been described for
embryonic tissues so far (Balbin et al., 2001), McolA
transcripts could be detected in wild-type mice from day 1
to 5 after wounding (data not shown), and in wounds of
mmp13 / mice its expression level was marginally
reduced compared to control (Figure 5d). By
contrast, expression of neutrophil collagenase MMP8 was
significantly enhanced in wounds of mmp13 / mice, as
measured by Northern blot analysis and semiquantitative
PCR (Figure 5d, and data not shown). Immunohistochemical
analysis of wounds from control and mutant mice 3 days
post injury revealed no sign of additional cell types
expressing MMP8 at the wound sites of mmp13 / mice
(Figure S2).
Finally, we analyzed the expression levels of MMP2,
MMP3, and MMP14 (MT1-MMP), which exhibit collageno-
lytic activity, at least in vitro (Overall and Sodek, 1992; Sodek
and Overall, 1992; Ohuchi et al., 1997; Seandel et al., 2001;
Tam et al., 2002, 2004). The amount of these transcripts was
even slightly reduced in MMP13-deficient wounds except for
MMP14, which remained unchanged (Figure 5d).
These data demonstrate that a series of MMPs are
expressed during re-epithelialization. Some MMPs showed
enhanced or reduced expression in MMP13-deficient
wounds. Thus, most likely, the activity of one or multiple
members of the MMP family appears to be responsible for the
functional compensation of MMP13 deficiency.
DISCUSSION
MMPs are important players in tissue remodelling and repair
processes, in which they mediate proteolysis of the ECM
predominantly composed of fibrillar collagens. In the mouse,
in vivo collagenolytic activity has been widely attributed to
MMP13 activity, the major interstitial collagenase in this
species. In this study, we functionally determined the role of
this protease during tissue remodelling and repair processes,
such as skin development and cutaneous wound repair,
employing the powerful knockout technology. To achieve
MMP13 deficiency in mice, a targeted mmp13 locus with
floxed exons (Stickens et al., 2004) was inter-crossed with the
CMV-cre strain (Schwenk et al., 1995). Despite the fact that
MMP13 was suggested to be involved in postpartum
involution, at least in rats (Wolf et al., 1996), as well as in
very early embryo development (Yamamoto et al., 1998) and
in microvessel formation (Burbridge et al., 2002), we found
no impact of MMP13 deficiency on reproduction or
embryonic survival. Yet, in line with the massive expression
of MMP13 during long bone development (Gack et al., 1995)
and homeostasis (Tuckermann et al., 2000), MMP13 inacti-
vation caused abnormal skeletal growth plate development
(Inada et al., 2004; Stickens et al., 2004; unpublished data).
To date, MMP13 expression has only been detected during
endochondral ossification but not in embryonic or newborn
skin (Gack et al., 1995). In line with these data, the unaltered
skin architecture of the mmp13 / mice shows that this
member of the family of interstitial collagenases obviously
does not play a role during skin development and skin
homeostasis.
Mice that express a collagenase-resistant version of
collagen suffer from impaired tissue remodelling and
spontaneously develop skin fibrosis in aged unchallenged
animals (Liu et al., 1995), underscoring the need for
collagenolytic enzymes. However, our data strongly imply
that MMP13 is not the critical candidate, as no sign of fibrotic
depositions was seen in the skin of the mmp13 / mice,
even after 12 months of age. Thus, the assigned function of
MMP13, as an interstitial collagenase cleaving fibrillar
collagen in skin homeostasis, may be compensated by other
members of the MMP family such as MMP2 and MMP14
(MT1-MMP) in mmp13 mutant mice. It was shown previously
that both MMP2 and MP14 are expressed in unchallenged
skin (Madlener et al., 1998) and are capable of cleaving
−/−
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Figure 5. MMP expression analyses in the early phase of wound healing.
(a, b) In situ hybridization followed by H&E staining to detect MMP9
transcripts on sections of the left-hand site of wounds from (a) mmp13 4/4
and (b) mmp13 / mice. The arrow points to keratinocytes of the leading
wound edge. Bar: 50mm. (c) Northern blot analyses were performed with total
RNA prepared from day 1 and 2 wounds of mmp13 4/4 and mmp13 /
mice and hybridized to MMP13 and MMP9 cDNA. Quality and quantity of
the RNA was confirmed by visualization of GAPDH. (d) Semiquantitative PCR
of different MMPs performed on cDNA prepared on total RNA isolated from
day 1 wounds of mmp13 4/4 and mmp13 / mice. After gel
electrophoresis, PCR products of MMP8 and McolA were blotted and
hybridized to the corresponding PCR fragments. The autoradiograph was
scanned and reverted. b-Tubulin was used as an internal standard.
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fibrillar collagen, at least in vitro (Overall and Sodek, 1992;
Sodek and Overall, 1992; Ohuchi et al., 1997; Seandel et al.,
2001; Tam et al., 2002, 2004).
Similar to MMP3, MMP9, MMP8, MMP10, MMP11, and
Mcol-A (Madlener et al., 1998; Nwomeh et al., 1998; our
unpublished data), MMP13 expression is strongly upregu-
lated shortly after injury and declines when re-epitheliali-
zation is completed (Madlener et al., 1998; Nwomeh et al.,
1998; Lund et al., 1999). In the early phase of wound healing,
MMP13 transcripts are found in the migrating keratinocytes
located at the wound edges, and at later phases of wound
repair when re-epithelialization is completed, insular fibro-
blasts express the enzyme in the granulation tissue (Madlener
et al., 1998; Wu et al., 2003; our unpublished data). Mice
expressing a collagenase-resistant version of collagen dis-
played a severely delayed wound healing (Beare et al., 2003),
demonstrating the need for collagenases in healing of the
injured skin, even though the identity of the specific MMP in
charge is not clear. Upon performing excisional wounding
experiments on the back skin of mmp13 / and control
mice, we observed no significant effects on the wound
healing process. Angiogenesis and collagen network assem-
bly in the area of the former wound bed are unimpaired.
Although MMP13 is strongly upregulated during the early
phase of wound healing, we found no changes in re-
epithelialization, epidermal re-organization, granulation tis-
sue formation, inflammatory response, re-assembly of the
basement membrane, and tissue remodelling in mmp13 /
mice. These results are in agreement with data from wound
healing studies performed in mice deficient for other MMPs.
Except for mice lacking MMP14, which develop fibrosis of
the dermis in unchallenged skin (Holmbeck et al., 1999,
2004), none of the MMP knockout mice generated so far
displayed a severe phenotype in wound healing (Bullard
et al., 1999; Mohan et al., 2002; Mauch, 2003).
Based on these results, it is reasonable to postulate that
skin development, homeostasis, and wound healing do not
rely on a single proteinase, but rather benefit from the
availability of an array of MMPs that are simultaneously
expressed. Facing the fact that most MMPs exhibit broad
substrate specificity and that many MMPs share the same
substrates (McCawley and Matrisian, 2001; Sternlicht and
Werb, 2001), redundancy among the MMPs can be
postulated. Collagen type I, being the preferential substrate
of MMP13, together with collagen type II and III (Kna¨uper
et al., 1996; McCawley and Matrisian, 2001; Sternlicht and
Werb, 2001) can also be cleaved by non-MMP proteolytic
enzymes such as serine proteases (Hibbs et al., 1983; Dano
et al., 1985; Kofford et al., 1997; Ashcroft et al., 2000;
Behrendt, 2004; Iba et al., 2004; Provenzano et al., 2005). A
role in ECM degradation and tissue remodelling during
cutaneous wound healing has already been demonstrated for
the serine protease plasmin, which is the effector protease of
the urokinase plasminogen activator system (Romer et al.,
1991, 1994, 1996). Hence, we suggest that collagenolytic
proteases other than MMP13 may also substitute for the loss
of collagenolytic activity in mmp13 / mice during these
processes.
One obvious candidate for the compensatory assignment
by MMP family members is MMP9, which, like MMP13, is
expressed by keratinocytes of the leading wound edge.
Moreover, MMP9 was found in mmp13 / mice to be
upregulated during embryonic bone development and was
shown to synergize with MMP13 during endochondral
ossification (Inada et al., 2004; Stickens et al., 2004).
However, monitoring MMP9 expression in wounds of
MMP13-deficient mice 1 and 2 days post injury revealed
no significant increases in the level of MMP9 transcripts.
Furthermore, the mild epidermal wound closure phenotype
observed in mmp9 knockout mice was not further impaired
by an additional loss of MMP13 in mmp9/mmp13 double-
knockout animals (B. Hartenstein, B. Dittrich, B. Arnold, and
P. Angel, unpublished data). These data suggest that in
contrast to the process of endochondral ossification, MMP9
does not compensate for the loss of collagenase activity
during cutaneous wound healing in MMP13-deficient mice.
Similarly, another candidate for substitution of MMP13,
MMP14, a proteinase with the capacity to cleave native
collagen (Tam et al., 2004) and which is expressed during
wound healing (Madlener et al., 1998) and upregulated in
bones of mmp13 / embryos (Inada et al., 2004), also
remained unchanged at the mRNA transcript level in
MMP13-deficient wounds.
Interestingly, we detected enhanced expression of MMP8
in the early phase of cutaneous wound healing in MMP13-
deficient mice, corresponding with the induced expression
level of this neutrophil-specific collagenase in bone marrow
cavities of newborn mmp13/ mice (Inada et al., 2004).
Although expression of MMP8 has recently been detected in
a number of other cell types (Wang et al., 2004), neutrophils
that infiltrate the granulation tissue are postulated to be the
main source of MMP8 in wounds (Balbin et al., 1998;
Madlener et al., 1998; Armstrong and Jude, 2002). As
quantification of the number of neutrophils in the granulation
tissue of mmp13/ wounds was unchanged and no
additional cell types, such as keratinocytes, exhibited
MMP8 protein in mutant wounds, augmented MMP8
transcript levels in skin very likely originated from enhanced
expression of this gene in neutrophils by an as yet unknown
mechanism. Thus, increased MMP8 activity may be one of
the events during the process of cutaneous wound healing in
mmp13 null mice that counteracts the harmful consequences
of reduced collagenolytic activity caused by MMP13
deficiency.
In humans, cutaneous wound healing is associated with
the induction of another interstitial collagenase, MMP1,
which shares a broad overlap in substrate specificity with
MMP13, at least in vitro (McCawley and Matrisian, 2001;
Sternlicht and Werb, 2001). Facing the fact that a true
homologue for MMP1 has not been identified in mice, the
issue of functional redundancy in humans might be even
more complicated and has to additionally take into account
MMP1.
In the face of functional redundancy in skin homeostasis
and remodelling, future analyses of isolated cell types, such
as keratinocytes, in appropriate tissue culture systems
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mimicking the in vivo situation, as well as wound healing
studies on skin of a variety of knockout mice that are deficient
for multiple MMPs, will have to be performed in order to
identify the nature of cooperating MMPs and to unravel the
underlying molecular mechanism of this functional collage-
nolytic network, which is obviously absolutely required for
survival of a complex higher organism.
MATERIALS AND METHODS
Mice
To generate MMP13-deficient mice, floxed mmp13 mice (Stickens
et al., 2004) were crossed to CMV-cre mice (Schwenk et al., 1995),
ensuring ubiquitous disruption of the mmp13 gene. The mice used
were in a mixed genetic background (C57BL/6;129/SV). The
recombination of the floxed mmp13 alleles was analyzed by
Southern and Northern blotting. All mice were housed in specific
pathogen-free environment and under light-, temperature-, and
humidity-controlled conditions. Food and water were available ad
libitum. The procedures for performing animal experiments were in
accordance with the principles and guidelines of the ATBW (officials
for animal welfare) and were approved by the Regierungspra¨sidium
Karlsruhe, Germany.
Wounding study
Control (floxed mmp13) and MMP13-deficient female mice aged 7–8
weeks were anesthetized with Ketanest and four paired 4mm
diameter, full-thickness, excisional wounds were made using a
sterile biopsy punch through the shaved and fumigated skin on the
back of each mouse. At 1, 2, 3, 5, 7, and 14 days post wounding,
mice were killed by cervical dislocation and wound tissue and
surrounding wound margin skin were harvested and embedded in
O.C.T.TM Compound (Tissue Tek, Vogel, Giessen, Germany). For
each time point, 6–8 wounds originating from different mice were
analyzed. Cryosections (5mm) of the wounds were stained with H&E
and documented using a Leica (DMLB) microscope.
Immunofluorescence analyses and immunohistochemistry
Cryosections (5mm) of wounds and tail skin were stained with the
following antibody solutions: rabbit anti-mouse loricrin (1:100;
BAbCo, Richmond, CA), rabbit anti-mouse keratin-10 (1:250;
BAbCo, Richmond, CA), rat anti-mouse CD68 (1:100; Serotec,
Du¨sseldorf, Germany), rat anti-mouse neutrophils (1:400; Serotec,
Du¨sseldorf, Germany), rat anti-mouse CD31 (1:100; Pharmingen,
Heidelberg, Germany), rabbit anti-human MMP8 (1:500; Chemicon
Europe, Hampshire, UK), rabbit anti-human laminin-5 g2 (1:2,000;
kindly provided by Dr G. Meneguzzi), rat anti-mouse a6-integrin
(1:400; kindly provided by Professor A. Sonnenberg), rabbit anti-
mouse involucrin (1:800; kindly provided by Professor F. Watt), and
guinea-pig anti-human keratin-5 (1:500; generous gift from Dr
L. Langbein).
For immunofluorescence analyses, cryosections were fixed in
100% methanol (41C) for 1minute and acetone (201C) for 2
minutes (a6-integrin, laminin-5), in 80% methanol (41C) for 5
minutes and acetone (201C) for 2 minutes (neutrophils, CD31,
CD68), in acetone (201C) for 2 minutes (keratin-5, keratin-10,
loricrin), in 80% methanol (room temperature) for 5 minutes
(MMP8), or left unfixed (involucrin). For MMP8, cryosections were
incubated for 20 minutes in citrate buffer (2mM citric acid, 10mM
tri-sodium citrate, pH 6.0) at 851C with subsequent rinsing in
phosphate-buffered saline (PBS). Cryosections were then blocked
with 1% BSA (Sigma, Deisenhofen, Germany) in PBS and incubated
with the primary antibodies diluted in the blocking solution for 2
hours at room temperature (a6-integrin, keratin-10, loricrin, laminin-
5) or overnight at 41C (CD31, CD68, neutrophils, MMP8, involucrin,
keratin-5). Subsequently, sections were washed with PBS and
incubated with Cy3-conjugated goat anti-rat secondary antibody
(for a6-integrin, CD31, neutrophils, CD68; 1:400; Dianova, Hamburg,
Germany), Cy3-conjugated goat anti-rabbit secondary antibody
(for involucrin, loricrin; 1:400; Dianova, Hamburg, Germany),
Cy2-conjugated goat anti-rabbit secondary antibody (for keratin-
10; 1:400; Dianova, Hamburg, Germany), Cy2-conjugated donkey
anti-guinea-pig secondary antibody (for keratin-5; 1:400; Dianova,
Hamburg, Germany), or Alexa-488-conjugated goat anti-rabbit
secondary antibody (for laminin-5, MMP8; 1:400; Molecular Probes,
Go¨ttingen, Germany) for 1hour at room temperature. The nuclei
were counterstained with Hoechst dye H33342 (1:1,000; Calbiochem-
Novabiochem, Schwalbach, Germany). Finally, the cryosections were
rinsed and mounted.
For immunohistochemistry, cryosections were fixed in 100%
methanol (41C) for 5 minutes and acetone (41C) for 10 minutes. After
rinsing with PBS, endogenous peroxidase was quenched with 3%
H2O2 in methanol for 10 minutes at room temperature. The
cryosections were then blocked with 1% BSA (Sigma, Deisenhofen,
Germany) in PBS and incubated with the primary antibodies
(keratin-10, loricrin) diluted in blocking solution for 1 hour at room
temperature and followed by incubation with a peroxidase-coupled
secondary antibody plus streptavidin–peroxidase complex and DAB
staining (Vectastain ABC kit, Vector Laboratories, Burlingame, UK).
Sections were counterstained with hematoxylin.
Collagen staining
Cryosections (5mm) of wounds and back skin were stained with
Picrosirius red as described elsewhere (Junqueira et al., 1979) and
imaged on a Zeiss Axioplan microscope. Images were captured
using a Hamamatsu 3 CCD cooled camera (Hamamatsu,
Hamamatsu City, Japan) and Simple PCI imaging software (Compix
Imaging Systems, Pittsburgh, PA).
RNA extraction, Northern blotting, and reverse
transcription-PCR
Total RNA was extracted from wounds 1 day after injury using the
peqGold RNAPureTM kit (PeqLab, Erlangen, Germany) following the
manufacturer’s protocol. For Northern blot analysis, 10mg of total
RNA was denatured in glyoxal/DMSO buffer (1M Glyoxal, 10mM
Na2HPO4 (pH 6.9), and 50% DMSO) and electrophoresed on a
1.4% agarose gel in 10mM Na2HPO4 (pH 6.9), blotted onto Hybond
Nþ membrane (Amersham Pharmacia Biotechnology, Freiburg,
Germany), and hybridized at 651C overnight with Church-Gilbert
hybridization buffer (1mM EDTA, 0.25M NaPi, 7% SDS). As probes,
the complete cDNA for MMP13 (Gack et al., 1995) and a BamHI/
XhoI fragment of the MMP9 cDNA spanning exon 3 to exon 8
(Reponen et al., 1995) were used. A cDNA probe for rat GAPDH
was taken as an internal control for RNA quality and quantity.
Probe labelling with [32P]dCTP was performed using the RediPrimeTM
Labelling kit (Amersham Pharmacia Biotechnology, Freiburg,
Germany).
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Single-strand cDNAs were synthesized from 1mg of total RNA
using AMV reverse transcriptase and oligo(dT) as primer (Promega,
Mannheim Germany); reverse transcriptase products were amplified
by semiquantitative PCR for different MMPs to compare transcript
amounts. All PCR primer pairs used are intron-spanning on separate
exons: MMP2 (495bp) sense 50-ccgggagcgcaagatgga-30 and antisense
50-gagaaaagcgcagcggagtgacg-30, MMP3 (673bp) sense 50-attgcatga
cagtgcaaggg-30 and antisense 50-tggaggacttgtagactggg-30, MMP8
(484bp) sense 50-ggcagaggaaggcaggagagg-30 and antisense 50-aaggt
caggggcgatgctacact-30, MMP14 (516bp) sense 50-ggcctgcctgcatccat
caata-30 and antisense 50-actgccctcctcatccacctcaat-30, Mcol-A
(374bp) sense 50-gaccttccccaaatcccatcc-30 and antisense 50-ctcttcc
tcacaaacagcagcatc-30. b-Tubulin (401bp) was used as an internal
standard using the primers sense 50-gcgacctgcagctggaccgaatct-30
and antisense 50-gggcgagggcaccacactgaagg-30. For Mcol-A and MMP8,
after electrophoresis the PCR products were blotted onto Hybond Nþ
membrane and hybridized at 651C overnight with Church-Gilbert
hybridization buffer. Hybridizations were performed with the
corresponding PCR fragments as probes.
In situ hybridization
For in situ hybridization, 5mm cryosections from wounds were
treated and hybridized with 35S-UTP-labelled sense and antisense
probes, as described previously (Tuckermann et al., 2000). MMP13
cRNA antisense probe spanning exon 5 to exon 3 (246bp including
nucleotides 595 to 429 of the published sequence) was derived by
sp6 in vitro transcription from a plasmid containing an MMP13
cDNA fragment spanning exon 1 to exon 5 linearized at an internal
StuI site. MMP9 cRNA antisense probe spanning exon 8 to exon 2
(904bp including nucleotides 1,275 to 371 of the published
sequence) was derived by T7 in vitro transcription from plasmid
linearized at a NotI site.
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SUPPLEMENTARY MATERIAL
Figure S1. Distance measurements between wound edges of mmp13 4/4
and mmp13 / mice. Distances were measured by ruler tool of Adobe
Photoshop 7.0s software on different H&E and involucrin stained sections of
different wounds (n) of day 1, 2, 3, 5 and 7 from mmp13 4/4 (black dots)
and mmp13/ mice (red dots).
Figure S2. Histological localization of MMP8 protein at wound sites of
mmp13 4/4 (upper panel) and mmp13 / (lower panel) 3 days post injury
(a, b) Neutrophils were stained by immunofluorescence using the antibody
neutrophils (red signal). Nuclei were counterstained with Hoechst dye (blue
signal). (c–f) MMP8 (c–d, green signal) was visualized by immunofluorescence
on parallel sections to (a) and (b), respectively. Nuclei were counterstained
with Hoechst dye (e-f, blue signal). Basement membrane is depicted by a
dashed line and the granulation tissue is highlighted by a dotted line. Bar:
100mm.
REFERENCES
Armstrong DG, Jude EB (2002) The role of matrix metalloproteinases in
wound healing. J Am Podiatr Med Assoc 92:12–18
Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T et al.
(2000) Secretory leukocyte protease inhibitor mediates non-redundant
functions necessary for normal wound healing. Nat Med 6:1147–53
Balbin M, Fueyo A, Knauper V, Pendas AM, Lopez JM, Jimenez MG et al.
(1998) Collagenase 2 (MMP-8) expression in murine tissue-remodeling
processes. Analysis of its potential role in postpartum involution of the
uterus. J Biol Chem 273:23959–68
Balbin M, Fueyo A, Knauper V, Lopez JM, Alvarez J, Sanchez LM et al. (2001)
Identification and enzymatic characterization of two diverging murine
counterparts of human interstitial collagenase (MMP-1) expressed at sites
of embryo implantation. J Biol Chem 276:10253–62
Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A et al. (2003)
Loss of collagenase-2 confers increased skin tumor susceptibility to male
mice. Nat Genet 35:252–7
Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P et al. (1997)
Matrix metalloproteinases as stromal effectors of human carcinoma
progression: therapeutic implications. Matrix Biol 15:535–41
Beare AH, O’Kane S, Krane SM, Ferguson MW (2003) Severely impaired
wound healing in the collagenase-resistant mouse. J Invest Dermatol
120:153–63
Behrendt N (2004) The urokinase receptor (uPAR) and the uPAR-associated
protein (uPARAP/Endo180): membrane proteins engaged in matrix
turnover during tissue remodeling. Biol Chem 385:103–36
Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G et al.
(2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release
of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells:
implications for ascites formation. Cancer Res 63:5224–9
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B,
DeCarlo A et al. (1993) Matrix metalloproteinases: a review. Crit Rev
Oral Biol Med 4:197–250
Bullard KM, Lund L, Mudgett JS, Mellin TN, Hunt TK, Murphy B et al. (1999)
Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg
230:260–5
Burbridge MF, Coge F, Galizzi JP, Boutin JA, West DC, Tucker GC (2002) The
role of the matrix metalloproteinases during in vitro vessel formation.
Angiogenesis 5:215–26
Clark RA (1996) Wound repair: overview and general consideration. In: The
molecular and cellular biology of wound repair. New York: Plenum
Press, 3–50
Dangelo M, Sarment DP, Billings PC, Pacifici M (2001) Activation of
transforming growth factor beta in chondrocytes undergoing endochon-
dral ossification. J Bone Miner Res 16:2339–47
Dano K, Andreasen PA, Grondahl-Hansen J, Kistensen P, Nielson LS, Skriver L
(1985) Plasminogen activators, tissue degradation, and cancer. Adv
Cancer Res 44:139–266
Devarajan P, Mookhtiar K, Van Wart H, Berliner N (1991) Structure and
expression of the cDNA encoding human neutrophil collagenase. Blood
77:2731–8
Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in
cancer progression. Nat Rev Cancer 2:161–74
Fuchs E (1990) Epidermal differentiation: the bare essentials. J Cell Biol
111:2807–14
Gack S, Vallon R, Schmidt J, Grigoriadis A, Tuckermann J, Schenkel J et al.
(1995) Expression of interstitial collagenase during skeletal development
of the mouse is restricted to osteoblast-like cells and hypertrophic
chondrocytes. Cell Growth Differ 6:759–67
Hangai M, Kitaya N, Xu J, Chan CK, Kim JJ, Werb Z et al. (2002) Matrix
metalloproteinase-9-dependent exposure of a cryptic migratory control
site in collagen is required before retinal angiogenesis. Am J Pathol
161:1429–37
Hibbs MS, Postlethwaite AE, Mainardi CL, Seyer JM, Kang AH (1983)
Alterations in collagen production in mixed mononuclear leukocyte-
fibroblast cultures. J Exp Med 157:47–59
494 Journal of Investigative Dermatology (2006), Volume 126
B Hartenstein et al.
Function of MMP13 in Cutaneous Wound Healing
Hieta N, Impola U, Lopez-Otin C, Saarialho-Kere U, Kahari VM (2003) Matrix
metalloproteinase-19 expression in dermal wounds and by fibroblasts in
culture. J Invest Dermatol 121:997–1004
Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ (1998) Matrix
metalloproteinases regulate neovascularization by acting as pericellular
fibrinolysins. Cell 95:365–77
Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA et al.
(1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthri-
tis, and connective tissue disease due to inadequate collagen turnover.
Cell 99:81–92
Holmbeck K, Bianco P, Yamada S, Birkedal-Hansen H (2004) MT1-MMP: a
tethered collagenase-1. J Cell Physiol 200:11–9
Iba Y, Shibata A, Kato M, Mosukawa T (2004) Possible involvement of mast
cells in collagen remodeling in the late phase of cutaneous wound
healing in mice. Int Immunopharmacol 4:1873–80
Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, Lopez-Otin C et al.
(2004) Critical roles for collagenase-3 (Mmp13) in development of
growth plate cartilage and in endochondral ossification. Proc Natl Acad
Sci USA 101:17192–7
Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus
polarization microscopy, a specific method for collagen detection in
tissue sections. Histochem J 11:447–55
Kna¨uper V, Lopez-Otin C, Smith B, Knight G, Murphy G (1996) Biochemical
characfterization of human collagenase-3. J Biol Chem 271:1544–50
Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF,
Graham MF (1997) Cleavage of type I procollagen by human mast cell
chymase initiates collagen fibril formation and generates a unique
carboxyl-terminal propeptide. J Biol Chem 272:7127–31
Krane SM, Byrne MH, Lemaitre V, Henriet P, Jeffrey JJ, Witter JP et al. (1996)
Different collagenase gene products have different roles in degradation
of type I collagen. J Biol Chem 271:28509–15
Langlois S, Gingras D, Beliveau R (2004) Membrane type 1-matrix
metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate
to induce endothelial cell migration and morphogenic differentiation.
Blood 103:3020–8
Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch R (1995) A targeted
mutation at the known collagenase cleavage site in mouse type I
collagen impairs tissue remodeling. J Cell Biol 130:227–37
Lund LR, Romer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL et al. (1999)
Functional overlap between two classes of matrix-degrading proteases in
wound healing. EMBO J 18:4645–56
Lynch CC, Matrisian LM (2002) Matrix metalloproteinases in tumor–host cell
communication. Differentiation 70:561–73
Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs)
and their physiological inhibitors (TIMPs) are differentially expressed
during excisional skin wound repair. Exp Cell Res 242:201–10
Mariani TJ, Sandefur S, Roby JD, Pierce RA (1998) Collagenase-3 induction in
rat lung fibroblasts requires the combined effects of tumor necrosis
factor-alpha and 12-lipoxygenase metabolites: a model of macrophage-
induced, fibroblast-driven extracellular matrix remodeling during in-
flammatory lung injury. Mol Biol Cell 9:1411–24
Massova I, Kotra LP, Fridman R, Mobashery S (1998) Matrix metallo-
proteinases: structures, evolution, and diversification. FASEB J 12:
1075–95
Matrisian LM (1992) The matrix-degrading metalloproteinases. BioEssays
14:455–63
Mauch C (2003) Matrix metalloproteinase-19: what role does this enzyme
play in wound healing? J Invest Dermatol 121:xix–xx
Mauch C, Eckes B, Hunzelmann N, Oono T, Kozlowska E, Krieg T (1993)
Control of fibrosis in systemic scleroderma. J Invest Dermatol
100:92S–6S
McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they’re not just
for matrix anymore!. Curr Opin Cell Biol 13:534–40
Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, Russo LA et al. (2002)
Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects
epithelial regeneration. J Biol Chem 277:2065–72
Mohan R, Rinehart WB, Bargagna-Mohan P, Fini ME (1998) Gelatinase B/lacZ
transgenic mice, a model for mapping gelatinase B expression during
developmental and injury-related tissue remodeling. J Biol Chem
273:25903–14
Mott JD, Werb Z (2004) Regulation of matrix biology by matrix metallopro-
teinases. Curr Opin Cell Biol 16:558–64
Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H et al.
(2002) The integrin alpha(v)beta8 mediates epithelial homeostasis
through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol
157:493–507
Nagase H, Woessner JF (1999) Matrix metalloproteinases. J Biol Chem
274:21491–4
Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J et al. (2001)
Postnatal expression in hyaline cartilage of constitutively active human
collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest
107:35–44
Nwomeh BC, Liang HX, Diegelmann RF, Cohen IK, Yager DR (1998)
Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute
open human dermal wounds. Wound Repair Regen 6:127–34
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y (1997) Membrane type 1
matrix metalloproteinase digests interstitial collagens and other extra-
cellular matrix macromolecules. J Biol Chem 272:2446–51
Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P (1997)
Expression of matrix metalloproteinases during rat skin wound healing:
evidence that membrane type-1 matrix metalloproteinase is a stromal
activator of pro-gelatinase A. J Cell Biol 137:67–77
Overall CM, Sodek J (1992) Reciprocal regulation of collagenase, 72 kDa-
gelatinase, and TIMP gene expression and protein synthesis in human
fibroblasts induced by concanavalin A. Matrix (Suppl 1):209–11
Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC (1997)
The activity of collagenase-1 is required for keratinocyte migration on a
type I collagen matrix. J Cell Biol 137:1445–57
Planus E, Galiacy S, Matthay M, Laurent V, Gavrilovic J, Murphy G et al.
(1999) Role of collagenase in mediating in vitro alveolar epithelial
wound repair. J Cell Sci 112(Part 2):243–52
Provenzano PP, Alejandro-Osorio AL, Valhmu WB, Jensen KT, Vanderby Jr R
(2005) Intrinsic fibroblast-mediated remodeling of damaged collagenous
matrices in vivo. Matrix Biol 23:543–55
Ravanti L, Kahari VM (2000) Matrix metalloproteinases in wound repair
(review). Int J Mol Med 6:391–407
Reponen P, Leivo I, Sahlberg C, Apte SS, Olsen BR, Thesleff I et al. (1995) 92-
kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase
or TIMP-1 or TIMP-2, are highly expressed during mouse embryo
implantation. Dev Dyn 202:388–96
Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL et al. (1996)
Impaired wound healing in mice with a disrupted plasminogen gene. Nat
Med 2:287–92
Romer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dano K (1994) The receptor
for urokinase-type plasminogen activator is expressed by keratinocytes
at the leading edge during re-epithelialization of mouse skin wounds.
J Invest Dermatol 102:519–22
Romer J, Lund LR, Eriksen J, Ralfkiaer E, Zeheb R, Gelehrter TD et al. (1991)
Differential expression of urokinase-type plasminogen activator and its
type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol
97:803–11
Saarialho-Kere UK (1998) Patterns of matrix metalloproteinase and
TIMP expression in chronic ulcers. Arch Dermatol Res 290(Suppl):
S47–54
Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H (1994)
Expression of matrix metalloproteinase-2 and -9 during early human
wound healing. Lab Invest 70:176–82
Schenk S, Quaranta V (2003) Tales from the crypt[ic] sites of the extracellular
matrix. Trends Cell Biol 13:366–75
Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the
ubiquitous deletion of loxP-flanked gene segments including deletion in
germ cells. Nucleic Acids Res 23:5080–1
www.jidonline.org 495
B Hartenstein et al.
Function of MMP13 in Cutaneous Wound Healing
Seandel M, Noack-Kunnmann K, Zhu D, Aimes RT, Quigley JP (2001) Growth
factor-induced angiogenesis in vivo requires specific cleavage of fibrillar
type I collagen. Blood 97:2323–32
Seiki M (2002) The cell surface: the stage for matrix metalloproteinase
regulation of migration. Curr Opin Cell Biol 14:624–32
Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:
738–46
Sodek J, Overall CM (1992) Matrix metalloproteinases in periodontal tissue
remodelling. Matrix 1(Suppl):352–62
Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix
metalloproteinases. J Pathol 200:448–64
Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell
behavior. Annu Rev Cell Dev Biol 17:463–516
Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y et al. (2004)
Altered endochondral bone development in matrix metalloproteinase
13-deficient mice. Development 131:5883–95
Tam EM, Moore TR, Butler GS, Overall CM (2004) Characterization of the
distinct collagen binding and cleavage mechanisms of matrix metallo-
proteinase 2 and 14 (gelatinase A and MT1-MMP): the differential
roles of the MMP hemopexin C domains and the MMP-2 fibronectin type
II modules in collagen triple helicase activities. J Biol Chem 279:
43336–44
Tam EM, Wu YI, Butler GS, Stack MS, Overall CM (2002) Collagen binding
properties of the membrane type-1 matrix metalloproteinase (MT1-MMP)
hemopexin C domain. The ectodomain of the 44-kDa autocatalytic
product of MT1-MMP inhibits cell invasion by disrupting native type I
collagen cleavage. J Biol Chem 277:39005–14
Tuckermann JP, Pittois K, Partridge NC, Merregaert J, Angel P (2000)
Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are
marker genes of chondrogenic/osteoblastic cells in bone formation:
sequential temporal, and spatial expression of Itm2a, alkaline phospha-
tase, MMP-13, and osteocalcin in the mouse. J Bone Miner Res
15:1257–65
Vu TH, Werb Z (2000) Matrix metalloproteinases: effectors of development
and normal physiology. Genes Dev 14:2123–33
Wang H, Parry S, Macones G, Sammel MD, Ferrand PE, Kuivaniemi H et al.
(2004) Functionally significant SNP MMP8 promoter haplotypes and
preterm premature rupture of membranes (PPROM). Hum Mol Genet
13:2659–69
Warner RL, Bhagavathula N, Nerusu KC, Lateef H, Younkin E, Johnson KJ
et al. (2004) Matrix metalloproteinases in acute inflammation: induction
of MMP-3 and MMP-9 in fibroblasts and epithelial cells following
exposure to pro-inflammatory mediators in vitro. Exp Mol Pathol
76:189–95
Werb Z, Vu TH, Rinkenberger JL, Coussens LM (1999) Matrix-degrading
proteases and angiogenesis during development and tumor formation.
APMIS 107:11–8
Wolf K, Sandner P, Kurtz A, Moll W (1996) Messenger ribonucleic acid levels
of collagenase (MMP-13) and matrilysin (MMP-7) in virgin, pregnant,
and postpartum uterus and cervix of rat. Endocrinology 137:5429–34
Wu N, Jansen ED, Davidson JM (2003) Comparison of mouse matrix
metalloproteinase 13 expression in free-electron laser and scalpel
incisions during wound healing. J Invest Dermatol 121:926–32
Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS et al. (2001)
Proteolytic exposure of a cryptic site within collagen type IV is required
for angiogenesis and tumor growth in vivo. J Cell Biol 154:1069–79
Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel
GW et al. (1998) Defective trophoblast function in mice with a targeted
mutation of Ets2. Genes Dev 12:1315–26
Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9
proteolytically activates TGF-beta and promotes tumor invasion and
angiogenesis. Genes Dev 14:163–76
496 Journal of Investigative Dermatology (2006), Volume 126
B Hartenstein et al.
Function of MMP13 in Cutaneous Wound Healing
